OBJECTIVE: Insulin has both growth-promoting and protective vascular effects in vitro, however the predominant effect in vivo is unclear. We investigated the effects of insulin in vivo on neointimal growth after arterial injury. METHODS AND RESULTS: Rats were given subcutaneous control (C) or insulin implants (3U/d;I) 3 days before arterial (carotid or aortic) balloon catheter injury. Normoglycemia was maintained by oral glucose and, after surgery, by intraperitoneal glucose infusion (saline in C). Insulin decreased intimal area (P<0.01) but did not change intimal cell proliferation or apoptosis. However, insulin inhibited cell migration into the intima (P<0.01) and increased expression of smooth muscle cell (SMC) differentiation markers (P<0.05). Insulin also increased reendothelialization (P<0.01) and the number of circulating progenitor cells (P<0.05). CONCLUSIONS: These results are the first demonstration that insulin has a protective effect on both SMC and endothelium in vivo, resulting in inhibition of neointimal growth after vessel injury.
OBJECTIVE: Insulin has both growth-promoting and protective vascular effects in vitro, however the predominant effect in vivo is unclear. We investigated the effects of insulin in vivo on neointimal growth after arterial injury. METHODS AND RESULTS:Rats were given subcutaneous control (C) or insulin implants (3U/d;I) 3 days before arterial (carotid or aortic) balloon catheter injury. Normoglycemia was maintained by oral glucose and, after surgery, by intraperitoneal glucose infusion (saline in C). Insulin decreased intimal area (P<0.01) but did not change intimal cell proliferation or apoptosis. However, insulin inhibited cell migration into the intima (P<0.01) and increased expression of smooth muscle cell (SMC) differentiation markers (P<0.05). Insulin also increased reendothelialization (P<0.01) and the number of circulating progenitor cells (P<0.05). CONCLUSIONS: These results are the first demonstration that insulin has a protective effect on both SMC and endothelium in vivo, resulting in inhibition of neointimal growth after vessel injury.
Authors: Jun Nelson; Yi Wu; Xiaohua Jiang; Remus Berretta; Steven Houser; Eric Choi; Jingfeng Wang; Jian Huang; Xiaofeng Yang; Hong Wang Journal: FASEB J Date: 2015-04-08 Impact factor: 5.191
Authors: Laurie K Bale; Zachary T Resch; Sara L Harstad; Michael T Overgaard; Cheryl A Conover Journal: Am J Physiol Endocrinol Metab Date: 2012-11-20 Impact factor: 4.310
Authors: Yan Zhao; Swarajit K Biswas; Patrick H McNulty; Mark Kozak; John Y Jun; Lakshman Segar Journal: Am J Physiol Cell Physiol Date: 2011-02-16 Impact factor: 4.249
Authors: Subramanyam N Murthy; Cyrus V Desouza; Neal W Bost; Rose-Claire St Hilaire; David B Casey; Adeleke M Badejo; Jasdeep S Dhaliwal; Jennifer McGee; Dennis B McNamara; Philip J Kadowitz; Vivian A Fonseca Journal: Diabetes Date: 2010-09-28 Impact factor: 9.461
Authors: June Guo; Troy J Pereira; Yusaku Mori; Marel Gonzalez Medina; Danna M Breen; Prasad S Dalvi; Hangjun Zhang; Declan F McCole; Michael W McBurney; Scott P Heximer; Evangelia L Tsiani; Vernon W Dolinsky; Adria Giacca Journal: J Vasc Res Date: 2020-08-10 Impact factor: 1.934